Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Stage 1 treatment of pediatric overweight and obesity: a pilot and feasibility randomized controlled trial
Steven D Stovitz1, Jerica M Berge, Rachel J Wetzsteon
11 Department of Family Medicine and Community Health, University of Minnesota , Minneapolis, MN.
Insights
This study tested the first stage of pediatric obesity treatment in children aged 4-9. The intervention showed feasibility and potential benefits for BMI and behavior, supporting further research into multi-stage obesity management.
Area of Science:
- Pediatric Endocrinology
- Public Health
- Behavioral Science
Background:
- Staged clinical treatment protocols for pediatric obesity are recommended but lack empirical testing.
- Understanding the effectiveness of the initial, least intensive treatment stage is crucial for developing comprehensive management strategies.
Purpose of the Study:
- To evaluate the feasibility and preliminary effectiveness of the lowest intensity stage of a recommended pediatric obesity treatment program.
- To compare changes in BMI z-score and behavioral issues in children receiving the intervention versus a control group.
Main Methods:
- A randomized controlled trial involving children aged 4 to <9 years with a BMI at or above the 85th percentile.
- Intervention based on the "Prevention plus, Stage 1" model.
- Intent-to-treat (ITT) analysis compared changes in BMI z-score and parental-reported behavioral issues over 3 months.
Main Results:
- Enrollment included 72 children, with 64 completing the 3-month follow-up.
- Both groups showed improvement in mean BMI z-score, with the intervention group demonstrating a slightly greater adjusted change (-0.04 vs. -0.07).
- Over half of children in both groups improved their BMI z-score; the intervention group had a higher proportion of improvement (72% vs. 55%).
- The intervention group showed comparative improvements in several behavioral indicators.
Conclusions:
- The initial stage of current pediatric obesity treatment recommendations is feasible to implement in primary care.
- This lowest intensity intervention may offer benefits for lifestyle changes and behavioral outcomes in children.
- Findings provide a basis for future research protocols testing comprehensive, multi-staged approaches for pediatric overweight and obesity.
Background:
Staged clinical treatment of pediatric obesity is recommended, but untested. Understanding the lowest intensity stage's effectiveness is necessary for future research.
Methods:
This was a randomized controlled trial of children ages 4 to <9 years. Participants were recruited after routine evaluations at a primary care pediatric clinic revealed a BMI ≥85th percentile. The intervention was patterned after the "Prevention plus, Stage 1" treatment recommended by an expert committee. Groups were compared for changes, over a 3-month time period, in BMI z-score and parental reports of behavioral issues related to childhood obesity using intent-to-treat (ITT) analysis.
Results:
Seventy-two (30% of eligible) children were enrolled and 64 were remeasured at 3-month follow-up. ITT analysis revealed that both groups improved mean BMI z-score [adjusted change -0.07, control, and -0.04, intervention; 95% confidence interval (CI) of difference=-0.14-0.20]. Over half of the children in each group improved their BMI z-score (adjusted proportion decreasing=55% in control vs. 72% in intervention; 95% CI of difference=-0.07-0.42). The intervention group improved comparatively to the control group on numerous behavioral indicators.
Conclusions:
Implementation of the lowest intensity stage of current recommendations is feasible and possibly of benefit toward lifestyle changes. Results of this study can be used by future clinical researchers designing protocols to test the full multi-staged approach for the treatment of pediatric overweight and obesity in primary care clinical settings.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Clinical Trials
There are four phases in a clinical trial. A phase one...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

